Asset Details
Do you wish to reserve the book?
Targeting cancer metabolism through p-cresol mediated Inhibition of pyruvate dehydrogenase kinase 3 in lung cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Targeting cancer metabolism through p-cresol mediated Inhibition of pyruvate dehydrogenase kinase 3 in lung cancer
Do you wish to request the book?
Targeting cancer metabolism through p-cresol mediated Inhibition of pyruvate dehydrogenase kinase 3 in lung cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Targeting cancer metabolism through p-cresol mediated Inhibition of pyruvate dehydrogenase kinase 3 in lung cancer
2025
Overview
This study provides insight into therapy for lung cancer, establishing
p-C
resol (
p-C)
as an inhibitor of Pyruvate Dehydrogenase Kinase 3 (PDK3). PDK3 is critical in cancer metabolism by regulating the pyruvate dehydrogenase complex, shifting cellular energy production towards glycolysis, and promoting tumor growth and survival under hypoxic conditions. In this study, we have used computational and experimental approaches. Molecular docking reveals that
p-C
occupies PDK3’s binding pocket and forms interactions with key residues, especially Asp 287. Molecular dynamic simulation (MD) studies showed that
p-C
induced minimum alterations in PDK3, suggesting the structural stability of the PDK3-
p-C
complex. A fluorescence-based binding study demonstrated the binding of
p-C
to PDK3 with a binding constant of 3.8 × 10
8
M
−1
, indicating excellent binding affinity. Cell-based enzyme assay revealed significant inhibition of PDK3 by
p-C
, establishing it as a PDK3 inhibitor. Moreover, cellular assays also demonstrated significant inhibition of PDK3 activity and tumor progression. This study provides a promising therapeutic avenue for improving lung cancer treatment outcomes by targeting PDK3.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ 631/67
/ Animals
/ Cresols
/ Humanities and Social Sciences
/ Humans
/ Hypoxia
/ Kinases
/ Ligands
/ Lung Neoplasms - drug therapy
/ Molecular Docking Simulation
/ Molecular dynamic simulation
/ Molecular Dynamics Simulation
/ Protein Kinase Inhibitors - chemistry
/ Protein Kinase Inhibitors - pharmacology
/ Proteins
/ Pyruvate dehydrogenase (lipoamide)
/ Pyruvate Dehydrogenase Acetyl-Transferring Kinase - antagonists & inhibitors
/ Pyruvate Dehydrogenase Acetyl-Transferring Kinase - chemistry
/ Pyruvate Dehydrogenase Acetyl-Transferring Kinase - metabolism
/ Pyruvate dehydrogenase kinase
/ Science
/ Tumors
We currently cannot retrieve any items related to this title. Kindly check back at a later time.